Sprycel Market Report Spreads In 81 Pages with 125 Tables and Figures
Sprycel Market 2023 : Dasatinib, sold under the brand name Sprycel, is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Sprycel is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Sprycel is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Sprycel is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Sprycel include Bristol-Myers Squibb and LUCIUS Pharma etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Top Key Players:
- Bristol-Myers Squibb
- LUCIUS Pharma
Sprycel Market By Applications
- CML
- ALL
Sprycel Market By Types
- 20mg
- 50mg
- 70mg
Get a Sample PDF of report –https://www.360researchreports.com/enquiry/request-sample/21708450
Paraffin Wax Market to See Massive Growth by 2028
Champaka Oil Market to Exhibit a Remarkable CAGR
Solvent Inks Market to See Exceptional Rise in Coming Years
The Kombu Powder Market is expected to grow at significant CAGR